Inhibitors Of Cathepsin S For Prevention Or Treatment Of Obesity-associated Disorders


The present invention relates to methods (and pharmaceutical compositions) for treating and/or preventing for obesity associated disorders, particularly related to a deregulation of glucose homeostasis, by administrating Cathepsin S inhibitors. The invention also relates to methods for diagnosing insulin resistance and glucose tolerance by measuring Cathepsin S levels in a biological sample obtained from a subject.

Download PDF
Document Preview
Document History
  • Publication: Sep 23, 2010
  • Application: Mar 22, 2010
    WO EP 2010053674 W
  • Priority: Feb 4, 2010
    EP EP 10305119 A
  • Priority: Mar 20, 2009
    EP EP 09305249 A

Download Citation

Sign in to the Lens